Renovaro (RENB) Competitors $0.28 0.00 (-0.47%) Closing price 03:53 PM EasternExtended Trading$0.29 +0.01 (+3.96%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RENB vs. IMMP, ACB, SLRN, CGC, TVGN, BTMD, INBX, DSGN, ESPR, and NBTXShould you be buying Renovaro stock or one of its competitors? The main competitors of Renovaro include Prima BioMed (IMMP), Aurora Cannabis (ACB), Acelyrin (SLRN), Canopy Growth (CGC), Semper Paratus Acquisition (TVGN), biote (BTMD), Inhibrx Biosciences (INBX), Design Therapeutics (DSGN), Esperion Therapeutics (ESPR), and Nanobiotix (NBTX). These companies are all part of the "pharmaceutical products" industry. Renovaro vs. Its Competitors Prima BioMed Aurora Cannabis Acelyrin Canopy Growth Semper Paratus Acquisition biote Inhibrx Biosciences Design Therapeutics Esperion Therapeutics Nanobiotix Prima BioMed (NASDAQ:IMMP) and Renovaro (NASDAQ:RENB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and dividends. Do analysts rate IMMP or RENB? Prima BioMed presently has a consensus price target of $7.00, suggesting a potential upside of 309.36%. Given Prima BioMed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Prima BioMed is more favorable than Renovaro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prima BioMed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Renovaro 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, IMMP or RENB? Prima BioMed has a beta of 1.71, meaning that its stock price is 71% more volatile than the S&P 500. Comparatively, Renovaro has a beta of 0.51, meaning that its stock price is 49% less volatile than the S&P 500. Which has better earnings and valuation, IMMP or RENB? Prima BioMed has higher revenue and earnings than Renovaro. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrima BioMed$5.14M48.59-$28.01MN/AN/ARenovaroN/AN/A-$88.43M-$0.77-0.36 Do institutionals & insiders hold more shares of IMMP or RENB? 2.3% of Prima BioMed shares are owned by institutional investors. Comparatively, 71.4% of Renovaro shares are owned by institutional investors. 3.1% of Prima BioMed shares are owned by company insiders. Comparatively, 21.7% of Renovaro shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media favor IMMP or RENB? In the previous week, Renovaro had 4 more articles in the media than Prima BioMed. MarketBeat recorded 4 mentions for Renovaro and 0 mentions for Prima BioMed. Renovaro's average media sentiment score of 0.42 beat Prima BioMed's score of 0.00 indicating that Renovaro is being referred to more favorably in the news media. Company Overall Sentiment Prima BioMed Neutral Renovaro Neutral Is IMMP or RENB more profitable? Prima BioMed's return on equity of 0.00% beat Renovaro's return on equity.Company Net Margins Return on Equity Return on Assets Prima BioMedN/A N/A N/A Renovaro N/A -60.38%-47.04% SummaryPrima BioMed beats Renovaro on 8 of the 12 factors compared between the two stocks. Get Renovaro News Delivered to You Automatically Sign up to receive the latest news and ratings for RENB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RENB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RENB vs. The Competition Export to ExcelMetricRenovaroMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.07M$2.91B$5.54B$8.95BDividend YieldN/A2.42%5.38%4.08%P/E Ratio-0.3621.5627.4020.04Price / SalesN/A281.10419.46118.60Price / CashN/A41.9536.6357.47Price / Book0.317.518.085.67Net Income-$88.43M-$55.05M$3.16B$248.47M7 Day Performance-20.37%3.16%2.12%2.90%1 Month Performance-3.47%5.92%4.43%5.75%1 Year Performance-82.41%5.82%35.62%21.36% Renovaro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RENBRenovaro1.181 of 5 stars$0.28-0.5%N/A-82.0%$48.07MN/A-0.3620News CoverageGap UpIMMPPrima BioMed0.9151 of 5 stars$1.52-5.0%$7.00+360.5%-9.6%$233.66M$5.14M0.002,021ACBAurora Cannabis0.2078 of 5 stars$3.91-4.2%N/A-1.1%$229.35M$246.72M35.551,073SLRNAcelyrinN/A$2.27flat$9.60+322.9%N/A$229.17MN/A-0.92135CGCCanopy Growth2.8148 of 5 stars$1.19-4.0%$2.00+68.1%-81.0%$227.99M$225.65M-0.293,150TVGNSemper Paratus Acquisition3.9974 of 5 stars$1.16-3.3%$7.10+512.1%+75.8%$220.67MN/A0.003Gap DownBTMDbiote2.6885 of 5 stars$4.01+1.3%$8.00+99.5%-45.2%$216.65M$197.19M6.57194INBXInhibrx Biosciences1.2517 of 5 stars$14.56-2.5%N/A+16.1%$216.12M$200K0.12166News CoverageDSGNDesign Therapeutics0.3947 of 5 stars$3.90+4.3%$4.00+2.6%+15.0%$212.32MN/A-3.9440ESPREsperion Therapeutics4.1413 of 5 stars$1.04-2.8%$7.00+573.1%-50.9%$212.07M$332.31M-1.30200NBTXNanobiotix1.7002 of 5 stars$4.45-0.5%$8.00+79.8%-7.1%$210.68M-$11.61M0.00100Gap Up Related Companies and Tools Related Companies Prima BioMed Alternatives Aurora Cannabis Alternatives Acelyrin Alternatives Canopy Growth Alternatives Semper Paratus Acquisition Alternatives biote Alternatives Inhibrx Biosciences Alternatives Design Therapeutics Alternatives Esperion Therapeutics Alternatives Nanobiotix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RENB) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovaro Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Renovaro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RENB Stock Alerts